Examine the patient's response and symptom improvement using the Integrated Approach to Symptom Management Model for the patients who has oral mucositis associated with hematologic cancer therapy

Examine the patient's response and symptom improvement using the Integrated Approach to Symptom Management Model for the patients who has oral mucositis associated with hematologic cancer therapy - The effect of Integrated Approach to Symptom Management for oral mucositis under hematologic cancer therapy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016948

Enrollment

Registered

2015-04-01

Start date

2015-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hematological malignancies oral mucositis associated with cancer therapy

Interventions

Period: to March 31st 2016 Frequency : 4 times First Intervention: 1)Interview according to guide book. Conduct observation of oral condition. 2)Understand the symptom experience of the patient a

s symptom experience. 2)Positive feedback. 3)Practice the above 3)4)5)6). Final Intervention: 1)Review and share the process for 4 weeks. 2)Recognize and identify patient&#39

s effort and make sure their achievement. 3)Measure the outcome scales.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patients undergoing hematologic cancer therapy 2)Patients who have the ability to communicate in Japanese and respond to the questionnaire without any cognitive disability.

Exclusion criteria

Exclusion criteria: 1)Patients undergoing myeloablative regimens for hematopoietic stem cell transplantation.

Design outcomes

Primary

Measure	Time frame
condition of oral hygiene include oral mucositis, mouth moist	—

Secondary

Measure	Time frame
self-efficacy scale for cancer patients SF-36v2 self-care ability (scale)	—

Countries

Japan

Contacts

Public ContactHiroe Nakano

University of Hyogo College of Nursing

hiroe_nakano@cnas.u-hyogo.ac.jp078-925-9434

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026

Examine the patient&#39;s response and symptom improvement using the Integrated Approach to Symptom Management Model for the patients who has oral mucositis associated with hematologic cancer therapy